IMMUNOVANT, INC. (IMVT) Net income 2019–2026
IMMUNOVANT, INC. (IMVT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$505.6MFY2026 · since FY2019: -$28.6M → -$505.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$505.6M | -22.2% |
| FY2025 | -$413.8M | -59.6% |
| FY2024 | -$259.3M | -22.9% |
| FY2023 | -$211.0M | -34.6% |
| FY2022 | -$156.7M | -45.9% |
| FY2021 | -$107.4M | -61.8% |
| FY2020 | -$66.4M | -132.1% |
| FY2019 | -$28.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice